Answers are grounded in this paper and cite their sources.
Stable nanoformulations of diruthenium( ii , iii )-NSAID metallodrugs encapsulated in intravenously injectable polymer-lipid NPs have been prepared and tested in cancer cells.
No takes yet. Share an insight, caveat, or question.
Alves et al. (2017) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: